NON-INVASIVE DIAGNOSTIC ALGORITHM FOR TUBULOINTERSTITIAL FIBROSIS IN CHRONIC GLOMERULONEPHRITIS BASED ON CLINICAL AND LABORATORY MARKERS

Auteurs

  • Javokhir Abdumurodov 1 Автор
  • Ozimbay Jabbarov 1 Автор

Résumé

Chronic glomerulonephritis (CGN) is one of the leading causes of end-stage renal disease worldwide, accounting for approximately 20–25% of all cases requiring renal replacement therapy (1). A critical determinant of renal prognosis in CGN is the degree of tubulointerstitial fibrosis (TIF), which reflects irreversible structural damage and correlates more strongly with long-term renal function decline than glomerular lesions alone (2). Traditionally, TIF assessment has relied on renal biopsy — an invasive procedure associated with significant risks and patient discomfort (3). Emerging non-invasive biomarkers, including TGF-β1, KIM-1 (kidney injury molecule-1), NGAL, and urinary α1-microglobulin, offer promising alternatives for monitoring fibrotic progression (4). However, no validated clinical-laboratory algorithm integrating these markers has been established for routine use (5). Development of such an algorithm would substantially improve early detection and management of TIF in CGN patients. 

 

Téléchargements

Publiée

2026-06-08

Numéro

Rubrique

Articles

Comment citer

Abdumurodov, J., & Jabbarov, O. (2026). NON-INVASIVE DIAGNOSTIC ALGORITHM FOR TUBULOINTERSTITIAL FIBROSIS IN CHRONIC GLOMERULONEPHRITIS BASED ON CLINICAL AND LABORATORY MARKERS. International Conference on Science, Education & Law, 2(6), 9-11. https://uniconflix.com/index.php/ICSEL/article/view/5196